You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 3, July 18, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Renal Diseases
 •Renal Diseases, Other
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Alert me on articles by topic

Statin Use and Sepsis in Patients With Chronic Kidney Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Gupta and colleagues1 found that the use of statins was independently associated with reduction in the risk of hospitalization for sepsis in patients with chronic kidney disease receiving dialysis. Several potential underlying mechanisms were invoked to explain an effect of statins, and we would like to add another possibility.

Statins increase the level of apolipoprotein (apo) A-I, the major protein component of high-density lipoprotein cholesterol, as well as the ratio of apo A-I to apo B.2 Apolipoprotein A-I has the ability to bind and clear lipopolysaccharide (endotoxin) and thereby protect against further lipopolysaccharide-induced cytokine activation.3 Furthermore, apo A-I can specifically block the interaction between activated T lymphocytes and monocytes, inhibiting production of tumor necrosis factor {alpha} and interleukin 1beta in monocytes in the serum of healthy volunteers.4 As a clinical equivalent of this laboratory finding, we showed that a low serum level of apo A-I in critically . . . [Full Text of this Article]

Catherine Chenaud, MD; Paolo Merlani, MD
paolo.merlani@hcuge.ch
Intensive Care Service
Department of Anesthesiology, Pharmacology and Intensive Care
University of Geneva Hospitals
Geneva, Switzerland


RELATED LETTER

Statin Use and Sepsis in Patients With Chronic Kidney Disease—Reply
Rajesh Gupta, Laura C. Plantinga, Josef Coresh, and Neil R. Powe
JAMA. 2007;298(3):284-285.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
Rajesh Gupta, Laura C. Plantinga, Nancy E. Fink, Michal L. Melamed, Josef Coresh, Caroline S. Fox, Nathan W. Levin, and Neil R. Powe
JAMA. 2007;297(13):1455-1464.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.